A new study has found the right dosage to administer a highly effective HIV treatment to newborns who are at risk of getting HIV.
Dolutegravir is one of the most effective and safest HIV medicines, and the preferred drug treatment recommended by the World Health Organization. It has been in use for more than a decade as an HIV treatment by millions of adults and adolescents living with HIV in over 100 countries. But there’s no specific drug formulation for newborns.
While many pregnant women have been taking dolutegravir for years to prevent mother-to-child transmission of HIV, this is not the case for everyone.